ACTIVATOR FOR MGD TREATMENT
Johnson & Johnson Vision announced the availability of the next-generation TearScience Activator Clear for the LipiFlow Thermal Pulsation System, the company’s fully automated in-office treatment for meibomian gland dysfunction. The new design of the Activator Clear features a single-piece eye cup and translucent design, enabling more efficient and accurate positioning in the eye, giving eye care professionals greater confidence that the activator is delivering heat and pressure evenly across the entire lid, the company says.
Johnson & Johnson Vision jjvision.com
OTC LINE OF EYE CARE PRODUCTS INTRODUCED
Théa Pharma Inc. introduced its iVIZIA OTC line of eye care products in the United States, now available at Amazon.com and CVS. The line includes lubricating eye drops, lubricating eye gel, eyelid cleansing wipes, a micellar eyelid cleanser, and an eyelid cleansing gel. Eye care professionals can request samples by visiting IVIZIA.com/ecp . The iVIZIA brand is distributed by Colorado-based Similasan Corporation.
Théa Pharma Inc. iVIZIA.com
VKC TREATMENT AVAILABLE
Santen Inc., announced that Verkazia (cyclosporine ophthalmic emulsion) 0.1% is now available in the United States for the treatment of vernal keratoconjunctivitis (VKC), a rare and recurrent allergic eye condition that causes severe inflammation of the surface of the eye. The eye drop is approved for the treatment of VKC in children and adults. The prescription-only, cationic nanoemulsion provides improved ocular bioavailability of cyclosporine, which has been shown to be effective in the management of VKC, the company says.
Santen Inc. www.verkazia.com
All information provided courtesy of the respective company.
![]({"src":"/media/qtsaamiu/cover_om_0622.jpg","focalPoint":null,"crops":[{"alias":"thumbnail","width":1110,"height":700,"coordinates":null}]})